{"slug":"sterilisation-dose-setting-iso-11137","title":"Radiation Sterilisation Dose Setting Under ISO 11137: Method 1, VDmax and Dose Audits","excerpt":"How a sterilisation dose is derived from measured bioburden, why VDmax has become the default for low-bioburden products, what a quarterly dose audit actually tests, and what happens when the audit fails.","date":"2026-07-09","author":"DSTechnoverse","image":"/blog-images/microbiology/bioburden-recovery-efficiency.svg","category":"Bioburden Testing","tags":["sterilisation dose setting","ISO 11137","VDmax","radiation sterilisation","dose audit","sterility assurance level","gamma sterilisation"],"content":"Radiation sterilisation is unusual among sterilisation methods in that the required dose is calculated from measured bioburden rather than fixed by a cycle recipe. That makes the bioburden number a direct input to sterility assurance, and it makes [ISO 11737-1](https://www.iso.org/standard/66451.html) bioburden testing a continuing obligation rather than a one-off validation activity.\n\n![Bioburden recovery efficiency by extraction method](/blog-images/microbiology/bioburden-recovery-efficiency.svg)\n\n## The Underlying Logic\n\nRadiation kills organisms following approximately first-order kinetics. The D₁₀ value is the dose required to reduce a population by one log. If a product carries 100 organisms and the target Sterility Assurance Level is 10⁻⁶, the dose must deliver eight log reductions — two to eliminate the initial population and six more to reach the target probability.\n\nBecause the organisms on a real product have a range of resistances, ISO 11137-2 uses a **standard distribution of resistances** derived from empirical data rather than assuming a single D₁₀. The methods below all rest on that distribution holding for your product.\n\n## Method 1\n\nThe classical approach, suited to products where bioburden is well characterised and may be moderately high.\n\n1. Determine average bioburden across at least three batches, ten units each, with recovery correction applied.\n2. Look up the corresponding **verification dose** from the ISO 11137-2 tables — the dose expected to give a 10⁻² SAL.\n3. Irradiate 100 units at the verification dose.\n4. Perform sterility tests on all 100. **No more than two positives** is the acceptance criterion.\n5. If the verification passes, look up the sterilisation dose for the target SAL from the same tables.\n6. If it fails, the standard resistance distribution does not hold for your product, and the dose must be established by another route.\n\n## VDmax\n\nThe maximum-dose method, now the default for most low-bioburden products because it is substantially less work.\n\nVDmax₂₅ substantiates a **fixed 25 kGy dose** for products whose average bioburden is below a defined threshold, currently 1,000 CFU. VDmax₁₅ does the same for 15 kGy where bioburden is below about 1.5 CFU, which suits well-controlled single-use components.\n\nThe verification is lighter: irradiate 10 units at the calculated verification dose and perform sterility tests, accepting **no more than one positive**. Where 25 kGy is materially above what the material tolerates, Method 1 may still give a lower dose and remain worth the extra effort.\n\n| Approach | Bioburden limit | Verification units | Acceptance |\n|---|---|---|---|\n| Method 1 | No fixed limit | 100 | ≤2 positives |\n| VDmax₂₅ | <1,000 CFU | 10 | ≤1 positive |\n| VDmax₁₅ | ~<1.5 CFU | 10 | ≤1 positive |\n\n## Dose Audits\n\nThe dose is not established once. ISO 11137 requires a **quarterly dose audit** confirming that the bioburden assumption still holds.\n\nAn audit consists of current bioburden determination on at least ten units, calculation of the verification dose from that bioburden, irradiation of the required units at the verification dose, and sterility testing against the acceptance criterion.\n\nA failed audit means the product's microbiological population has changed enough that the established dose may no longer deliver the target SAL — which calls into question product sterilised since the last successful audit.\n\n## When an Audit Fails\n\n1. **Confirm the result.** Rule out laboratory error in the sterility testing and verify the irradiation dose actually delivered using dosimetry records.\n2. **Determine current bioburden** on additional units to establish whether the count has risen, the composition has shifted, or both.\n3. **Assess the resistant fraction.** A rise in spore formers can fail an audit at an unchanged total count, and it points at a different source than a general count increase.\n4. **Investigate the cause** — raw materials, environment, water, personnel practices, in-process hold times, a new supplier or a process change.\n5. **Assess affected product.** Anything sterilised since the last successful audit is potentially implicated, and the assessment must be documented rather than assumed away.\n6. **Take corrective action** to restore bioburden, or re-establish the dose against the new population.\n7. **Repeat the audit** successfully before resuming routine release on the original dose.\n\nStep five is the one with the largest consequences and the one facilities most want to avoid. It is also exactly why quarterly monitoring is worth doing attentively — an audit failure discovered on schedule implicates one quarter of production, while an unmonitored drift implicates however long it took to notice.\n\n## Product Families and Bracketing\n\nRunning a full dose-setting exercise for every product variant is expensive, and ISO 11137 provides for grouping products into families where the microbiological challenge is genuinely comparable.\n\nA product family is justified on the basis that the members share manufacturing environment, raw materials, process, and — critically — bioburden level and composition. Where that holds, dose setting and dose audits can be performed on a representative or worst-case member rather than on every variant.\n\n- **Same manufacturing line and environment**, since environmental contribution is the shared factor.\n- **Same or equivalent materials**, because material affects both adherence and the organisms that colonise it.\n- **Comparable bioburden**, demonstrated with data rather than asserted. This is the element most often assumed.\n- **Comparable size and complexity**, since a larger or more intricate product presents more surface area and more crevices.\n- **The worst-case member selected on evidence** — normally the highest bioburden, the largest, or the most complex.\n- **Periodic verification of other members**, confirming the family assumption still holds rather than relying indefinitely on the original justification.\n\nFamilies are a legitimate efficiency and a common source of findings when the justification is thin. The question an auditor asks is straightforward: what data demonstrates these products present the same microbiological challenge? A grouping built on commercial similarity rather than microbiological similarity will not survive it.\n\n## Material Compatibility Sets the Ceiling\n\nDose setting is a negotiation between microbiology and materials science. Radiation degrades polymers, and the maximum tolerable dose is a real constraint.\n\nPolypropylene without stabilisers embrittles at relatively modest doses. PTFE degrades severely. Polycarbonate yellows. Adhesives, lubricants and printed markings all have their own limits, and the product must remain functional and non-toxic after the maximum dose it will ever receive — which includes the tolerance band above the specified minimum.\n\nWhere the required dose exceeds material tolerance, the options are to reduce bioburden so a lower dose suffices, switch to a radiation-stabilised material grade, or move to a different sterilisation method entirely. Reducing bioburden is frequently the cheapest of the three, and it is the one that microbiological control can deliver.\n\n## Ethylene Oxide and Steam Compared\n\nRadiation is the method where bioburden enters the calculation most directly, but it is not the only one where bioburden matters.\n\n**Ethylene oxide (ISO 11135)** typically uses a half-cycle approach — demonstrate no growth on biological indicators at half the intended exposure, then run the full cycle for a 10⁻⁶ SAL. Bioburden informs the choice of biological indicator and its placement in the hardest-to-reach location, and a high or unusually resistant bioburden challenges the assumption that the indicator is a worst case.\n\n**Moist heat (ISO 17665)** commonly uses an overkill approach where the delivered F₀ is so far above what the bioburden requires that the count becomes almost irrelevant. Where overkill is not achievable — for heat-sensitive products — a bioburden-based cycle is used and the count matters directly, along with the heat resistance of the resident spore population.\n\n## What Dosimetry Does and Does Not Cover\n\nDose setting involves two disciplines that are easy to conflate, and understanding the split clarifies who is responsible for what.\n\n**Dosimetry** is the physics. The irradiation provider measures delivered dose using calibrated dosimeters, maps the dose distribution across the load, establishes the minimum and maximum dose positions, and demonstrates that every unit in a load receives at least the specified minimum. Dose uniformity ratio — the maximum divided by the minimum — is a dosimetry parameter, and it determines whether a product at the maximum position still tolerates the dose materially.\n\n**Microbiology** is everything the dose is calculated from. Bioburden determination, recovery correction, composition characterisation, verification dose sterility testing and quarterly audit testing all sit here.\n\nThe two meet at the specified minimum dose, and problems at that interface are common. A verification dose experiment is only valid if the units actually received the intended dose, which means dosimetry records must accompany the microbiological result. An audit failure investigation should always check the delivered dose before concluding that bioburden changed — occasionally the microbiology is fine and the irradiation was short.\n\nManufacturers frequently outsource irradiation and assume the provider owns dose setting entirely. They own the dosimetry. The bioburden inputs, and the obligation to keep them current, remain with the manufacturer.\n\n## How DSTechnoverse Helps\n\nWe provide the microbiological half of dose setting and dose maintenance, working alongside the irradiation provider who handles dosimetry.\n\nThat covers bioburden determination with validated extraction and recovery correction, initial characterisation including spore fraction, verification dose experiment support, quarterly dose audit bioburden and sterility testing, trend analysis so a drift is visible before it fails an audit, audit failure investigation including composition analysis and source attribution, and documentation for notified bodies and regulatory submissions.\n\nOur laboratory is in **Indore** and we support device manufacturers across India, including those using the irradiation facilities serving the western and central India device clusters.\n\n## Frequently Asked Questions\n\n### Why is 25 kGy so common?\n\nIt is the dose VDmax₂₅ substantiates for products with bioburden below 1,000 CFU, which covers most well-controlled devices. It is a substantiated dose rather than a universal standard, and using it without substantiation is not acceptable.\n\n### How often are dose audits required?\n\nQuarterly under ISO 11137. Reduced frequency is possible for products with a long stable history, but requires justification and is not the default.\n\n### What happens if bioburden rises but the audit still passes?\n\nThe audit passing means the dose remains substantiated, but a rising trend is a warning that the next one may not. Investigate the rise rather than waiting for a failure, since a failure implicates a quarter of production.\n\n### Can we lower the dose if bioburden falls?\n\nYes, and it is worth doing where material degradation is a concern. Re-establishing at a lower dose requires the full dose-setting exercise, but it may extend product shelf life and improve function.\n\n### Does recovery correction affect the dose?\n\nDirectly. An uncorrected bioburden understates the population, which produces a verification dose that is too low. The audit is then more likely to fail, and the established dose carries an unquantified deficit.\n\n### Can the same dose be used at a different irradiation facility?\n\nNot without transfer work. The specified minimum dose is a product property and travels with the product, but the dose mapping, dose uniformity ratio and load configuration are facility-specific. A facility with a wider dose uniformity ratio will deliver a higher maximum dose to reach the same minimum, which may push the product past its material tolerance even though the microbiological requirement is unchanged. Transferring requires new dose mapping at the receiving facility and confirmation that the maximum dose remains acceptable.\n\n### What records should a dose-setting file contain?\n\nThe bioburden data with recovery correction applied and the correction study behind it, the verification dose calculation showing which table and which method were used, the dosimetry records for the verification irradiation, the sterility test results with their acceptance criterion, the resulting specified minimum dose, and the product family justification if grouping was used. The element most often missing is the recovery correction study — without it, the bioburden figure that everything else derives from is unsupported, and the whole file rests on it.\n\n### How does electron beam differ from gamma for dose setting?\n\nThe microbiology is identical — the same ISO 11137-2 methods, the same bioburden inputs, the same verification dose logic. The differences are physical. Electron beam delivers the dose in seconds rather than hours, which reduces oxidative degradation in some polymers and can allow a higher dose on a material that gamma would damage. Penetration is lower, so product density and packaging configuration matter more. X-ray sits between the two. The choice is a materials and throughput decision, not a microbiological one.\n\n### What if our product cannot tolerate the required dose?\n\nReduce bioburden so a lower dose suffices, change to a radiation-stable material grade, or use a different sterilisation method. Bioburden reduction is often the cheapest route and is where [environmental and raw material control](/services/raw-material-microbiological-testing) pays back.\n\n---\n\n**An uncorrected bioburden number understates the real load by a factor nobody has measured.** DSTechnoverse provides [bioburden testing](/services/bioburden-testing) under ISO 11737-1 with validated extraction, recovery efficiency correction and quarterly monitoring. Based in **Indore, Madhya Pradesh**, serving device and pharmaceutical manufacturers across India. [Talk to our microbiology team](/contact).","related":[{"slug":"bacterial-endotoxin-testing-lal","title":"Bacterial Endotoxin Testing: Why a Sterile Product Can Still Be Pyrogenic"},{"slug":"bioburden-testing-iso-11737","title":"Bioburden Testing Under ISO 11737-1: Extraction, Recovery and Why the Raw Count Is Wrong"}]}